SOLA Pharmaceuticals, LLC drugs

19 results
  • baclofen

    (BACLOFEN)
    SOLA Pharmaceuticals, LLC
    Baclofen tablets, USP are indicated for alleviating spasticity signs and symptoms from multiple sclerosis, including flexor spasms, pain, and rigidity. They may benefit patients with spinal cord injuries but are not recommended for rheumatic disorders, stroke, cerebral palsy, or Parkinson's disease due to unestablished efficacy.
  • carboprost tromethamine

    (carboprost tromethamine)
    SOLA Pharmaceuticals, LLC
    Carboprost tromethamine injection is indicated for aborting pregnancies between the 13th and 20th weeks, addressing complications like failed expulsion or ruptured membranes. It is also used to treat postpartum hemorrhage due to uterine atony that hasn't responded to standard treatments, helping to control life-threatening bleeding.
  • diclofenac potassium

    (diclofenac potassium)
    SOLA Pharmaceuticals, LLC
    Diclofenac potassium tablets are indicated for the treatment of primary dysmenorrhea, relief of mild to moderate pain, and alleviation of signs and symptoms associated with osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration to minimize risks.
  • diclofenac potassium

    (diclofenac potassium)
    SOLA Pharmaceuticals, LLC
    Diclofenac potassium tablets are indicated for the treatment of primary dysmenorrhea, relief of mild to moderate pain, and alleviation of symptoms associated with osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration necessary.
  • dimethyl fumarate

    (Dimethyl Fumarate)
    SOLA Pharmaceuticals, LLC
    Dimethyl fumarate delayed-release capsules are indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS.
  • ibuprofen

    (ibuprofen)
    SOLA Pharmaceuticals, LLC
    Ibuprofen tablets are indicated for relieving symptoms of rheumatoid arthritis and osteoarthritis, treating mild to moderate pain, and managing primary dysmenorrhea. Use the lowest effective dose for the shortest duration based on individual treatment goals. Safety and effectiveness in children have not been established.